Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Tiny Channel Island With 65 Residents That Chefs And Foodies Go Out Of Their Way To Visit - 2German finance minister sees advantages of smartphones in schools
- 3Grammy nominations 2026: Full list of nominees in every major category, including Album of the Year and Best New Artist
- 4What really happens when 140 reality stars come face to face with their biggest fans
- 5NAFFIC, AWARE claim first China-EU DPP for textiles
- Kobe Bryant called this WNBA star the 'Gold Mamba.' She turned his advice to her into a tattoo.
- Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- Share your number one city visit transport that leaves a mark on the world wake up!
- Instructions to Utilize the Towing Highlights of the Slam 1500 Productively.
- Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- 'Set up an Army Radio station at President’s Residence': Source close to Katz slams Herzog
- Hundreds of kilos of protected plant seized by Israel Nature and Parks Authority in Golan
- Longtime United Launch Alliance CEO Tory Bruno resigns from space company. 'Finished the mission I came to do.'
- The most effective method to Decide the Best Auto Crash Attorney for Your Lawful Necessities
